Cargando…
Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia
PURPOSE: We aimed to conduct a validation in Spanish of the Validated Hemophilia Regimen Treatment Adherence Scale – Prophylaxis (VERITAS-Pro) questionnaire for use in patients with hemophilia under prophylactic treatment. PATIENTS AND METHODS: The VERITAS-Pro scale was adapted through a process of...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375636/ https://www.ncbi.nlm.nih.gov/pubmed/28392680 http://dx.doi.org/10.2147/PPA.S126828 |
_version_ | 1782519034252623872 |
---|---|
author | Cuesta-Barriuso, Rubén Torres-Ortuño, Ana Galindo-Piñana, Pilar Nieto-Munuera, Joaquín Duncan, Natalie López-Pina, José Antonio |
author_facet | Cuesta-Barriuso, Rubén Torres-Ortuño, Ana Galindo-Piñana, Pilar Nieto-Munuera, Joaquín Duncan, Natalie López-Pina, José Antonio |
author_sort | Cuesta-Barriuso, Rubén |
collection | PubMed |
description | PURPOSE: We aimed to conduct a validation in Spanish of the Validated Hemophilia Regimen Treatment Adherence Scale – Prophylaxis (VERITAS-Pro) questionnaire for use in patients with hemophilia under prophylactic treatment. PATIENTS AND METHODS: The VERITAS-Pro scale was adapted through a process of back translation from English to Spanish. A bilingual native Spanish translator translated the scale from English to Spanish. Subsequently, a bilingual native English translator translated the scale from Spanish to English. The disagreements were resolved by agreement between the research team and translators. Seventy-three patients with hemophilia, aged 13–62 years, were enrolled in the study. The scale was applied twice (2 months apart) to evaluate the test–retest reliability. RESULTS: Internal consistency reliability was lower on the Spanish VERITAS-Pro than on the English version. Test–retest reliability was high, ranging from 0.83 to 0.92. No significant differences (P>0.05) were found between test and retest scores in subscales of VERITAS-Pro. In general, Spanish patients showed higher rates of nonadherence than American patients in all subscales. CONCLUSION: The Spanish version of the VERITAS-Pro has high levels of consistency and empirical validity. This scale can be administered to assess the degree of adherence of prophylactic treatment in patients with hemophilia. |
format | Online Article Text |
id | pubmed-5375636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53756362017-04-07 Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia Cuesta-Barriuso, Rubén Torres-Ortuño, Ana Galindo-Piñana, Pilar Nieto-Munuera, Joaquín Duncan, Natalie López-Pina, José Antonio Patient Prefer Adherence Original Research PURPOSE: We aimed to conduct a validation in Spanish of the Validated Hemophilia Regimen Treatment Adherence Scale – Prophylaxis (VERITAS-Pro) questionnaire for use in patients with hemophilia under prophylactic treatment. PATIENTS AND METHODS: The VERITAS-Pro scale was adapted through a process of back translation from English to Spanish. A bilingual native Spanish translator translated the scale from English to Spanish. Subsequently, a bilingual native English translator translated the scale from Spanish to English. The disagreements were resolved by agreement between the research team and translators. Seventy-three patients with hemophilia, aged 13–62 years, were enrolled in the study. The scale was applied twice (2 months apart) to evaluate the test–retest reliability. RESULTS: Internal consistency reliability was lower on the Spanish VERITAS-Pro than on the English version. Test–retest reliability was high, ranging from 0.83 to 0.92. No significant differences (P>0.05) were found between test and retest scores in subscales of VERITAS-Pro. In general, Spanish patients showed higher rates of nonadherence than American patients in all subscales. CONCLUSION: The Spanish version of the VERITAS-Pro has high levels of consistency and empirical validity. This scale can be administered to assess the degree of adherence of prophylactic treatment in patients with hemophilia. Dove Medical Press 2017-03-27 /pmc/articles/PMC5375636/ /pubmed/28392680 http://dx.doi.org/10.2147/PPA.S126828 Text en © 2017 Cuesta-Barriuso et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Cuesta-Barriuso, Rubén Torres-Ortuño, Ana Galindo-Piñana, Pilar Nieto-Munuera, Joaquín Duncan, Natalie López-Pina, José Antonio Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia |
title | Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia |
title_full | Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia |
title_fullStr | Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia |
title_full_unstemmed | Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia |
title_short | Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia |
title_sort | validation of the veritas-pro treatment adherence scale in a spanish sample population with hemophilia |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375636/ https://www.ncbi.nlm.nih.gov/pubmed/28392680 http://dx.doi.org/10.2147/PPA.S126828 |
work_keys_str_mv | AT cuestabarriusoruben validationoftheveritasprotreatmentadherencescaleinaspanishsamplepopulationwithhemophilia AT torresortunoana validationoftheveritasprotreatmentadherencescaleinaspanishsamplepopulationwithhemophilia AT galindopinanapilar validationoftheveritasprotreatmentadherencescaleinaspanishsamplepopulationwithhemophilia AT nietomunuerajoaquin validationoftheveritasprotreatmentadherencescaleinaspanishsamplepopulationwithhemophilia AT duncannatalie validationoftheveritasprotreatmentadherencescaleinaspanishsamplepopulationwithhemophilia AT lopezpinajoseantonio validationoftheveritasprotreatmentadherencescaleinaspanishsamplepopulationwithhemophilia |